Enhancer hijacking determines extrachromosomal circular MYCN amplicon architecture in neuroblastoma.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
16 11 2020
Historique:
received: 20 12 2019
accepted: 30 09 2020
entrez: 17 11 2020
pubmed: 18 11 2020
medline: 26 11 2020
Statut: epublish

Résumé

MYCN amplification drives one in six cases of neuroblastoma. The supernumerary gene copies are commonly found on highly rearranged, extrachromosomal circular DNA (ecDNA). The exact amplicon structure has not been described thus far and the functional relevance of its rearrangements is unknown. Here, we analyze the MYCN amplicon structure using short-read and Nanopore sequencing and its chromatin landscape using ChIP-seq, ATAC-seq and Hi-C. This reveals two distinct classes of amplicons which explain the regulatory requirements for MYCN overexpression. The first class always co-amplifies a proximal enhancer driven by the noradrenergic core regulatory circuit (CRC). The second class of MYCN amplicons is characterized by high structural complexity, lacks key local enhancers, and instead contains distal chromosomal fragments harboring CRC-driven enhancers. Thus, ectopic enhancer hijacking can compensate for the loss of local gene regulatory elements and explains a large component of the structural diversity observed in MYCN amplification.

Identifiants

pubmed: 33199677
doi: 10.1038/s41467-020-19452-y
pii: 10.1038/s41467-020-19452-y
pmc: PMC7669906
doi:

Substances chimiques

DNA, Circular 0
Histones 0
N-Myc Proto-Oncogene Protein 0
Lysine K3Z4F929H6

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5823

Subventions

Organisme : Wellcome Trust
ID : 206475/Z/17/Z
Pays : United Kingdom
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States

Références

Bioinformatics. 2015 Oct 15;31(20):3350-2
pubmed: 26099265
Bioinformatics. 2014 Apr 1;30(7):923-30
pubmed: 24227677
Genome Biol. 2014;15(12):550
pubmed: 25516281
Nucleic Acids Res. 2020 Jan 8;48(D1):D87-D92
pubmed: 31701148
BMC Bioinformatics. 2018 Sep 6;19(1):313
pubmed: 30189838
Nature. 2014 Jul 24;511(7510):428-34
pubmed: 25043047
Nature. 2015 Oct 29;526(7575):700-4
pubmed: 26466568
Bioinformatics. 2018 Sep 15;34(18):3094-3100
pubmed: 29750242
Bioinformatics. 2020 Aug 07;:
pubmed: 32766814
Nature. 2012 Aug 2;488(7409):49-56
pubmed: 22832581
Nat Genet. 2017 Sep;49(9):1408-1413
pubmed: 28740262
Cell Stem Cell. 2012 Nov 2;11(5):633-48
pubmed: 22981823
Proc Natl Acad Sci U S A. 2010 Dec 14;107(50):21931-6
pubmed: 21106759
Sci Data. 2018 Oct 30;5:180240
pubmed: 30375995
J Clin Oncol. 2009 Jan 10;27(2):289-97
pubmed: 19047291
Genome Res. 2010 Sep;20(9):1198-206
pubmed: 20631050
Nat Commun. 2019 Dec 9;10(1):5622
pubmed: 31819055
Nucleic Acids Res. 2016 Jul 8;44(W1):W160-5
pubmed: 27079975
Nat Genet. 2020 Jan;52(1):29-34
pubmed: 31844324
Cell. 2014 Dec 18;159(7):1665-80
pubmed: 25497547
Cell Syst. 2016 Jul;3(1):95-8
pubmed: 27467249
Cell. 2015 Aug 13;162(4):900-10
pubmed: 26276636
J Natl Cancer Inst. 2018 Oct 1;110(10):1084-1093
pubmed: 29514301
Mol Cell. 2019 Jun 20;74(6):1110-1122
pubmed: 31226276
Nat Protoc. 2012 Sep;7(9):1728-40
pubmed: 22936215
Bioinformatics. 2010 Mar 1;26(5):589-95
pubmed: 20080505
Sci Rep. 2016 Oct 31;6:36158
pubmed: 27796336
Nat Genet. 2019 Apr;51(4):705-715
pubmed: 30833795
Nature. 2016 Oct 13;538(7624):265-269
pubmed: 27706140
Nat Genet. 2017 Jan;49(1):65-74
pubmed: 27869826
Acta Neuropathol. 2019 Jan;137(1):123-137
pubmed: 30267146
Bioinformatics. 2012 Feb 1;28(3):423-5
pubmed: 22155870
Cell. 2020 Oct 1;183(1):197-210.e32
pubmed: 33007263
Nat Genet. 2015 Dec;47(12):1411-4
pubmed: 26523776
Hum Mol Genet. 2011 Apr 15;20(8):1488-501
pubmed: 21258086
Genome Res. 2014 Dec;24(12):2022-32
pubmed: 25236618
Genes Chromosomes Cancer. 2000 Dec;29(4):297-308
pubmed: 11066073
Science. 2014 Jan 3;343(6166):72-6
pubmed: 24310612
Nat Biotechnol. 2019 May;37(5):540-546
pubmed: 30936562
Nat Commun. 2018 Nov 19;9(1):4866
pubmed: 30451831
Oncogene. 2015 Jun;34(26):3357-68
pubmed: 25174395
Science. 2016 Mar 25;351(6280):1454-1458
pubmed: 26940867
Curr Protoc Mol Biol. 2015 Jan 05;109:21.29.1-21.29.9
pubmed: 25559105
Cell. 2019 Nov 27;179(6):1330-1341.e13
pubmed: 31761532
Nat Genet. 2018 Sep;50(9):1240-1246
pubmed: 30127528
Mol Cell. 2010 May 28;38(4):576-89
pubmed: 20513432
Cancer Res. 1989 Mar 15;49(6):1333-40
pubmed: 2647287
Cancer Discov. 2018 May;8(5):582-599
pubmed: 29510988
Bioinformatics. 2016 May 15;32(10):1555-6
pubmed: 26794315
Bioinformatics. 2018 Aug 1;34(15):2666-2669
pubmed: 29547981
Sci Transl Med. 2019 Jan 30;11(477):
pubmed: 30700572
Nucleic Acids Res. 2018 Jan 4;46(D1):D260-D266
pubmed: 29140473
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Nature. 2017 Mar 2;543(7643):122-125
pubmed: 28178237
Nature. 2016 Feb 4;530(7588):57-62
pubmed: 26814967
Nat Commun. 2019 Jan 23;10(1):392
pubmed: 30674876
Nature. 2018 Mar 15;555(7696):321-327
pubmed: 29489754
Nat Genet. 2018 Apr;50(4):515-523
pubmed: 29379199
EMBO J. 1997 Jun 2;16(11):2985-95
pubmed: 9214616
Sci Rep. 2019 Jun 27;9(1):9354
pubmed: 31249361
Nat Genet. 2018 May;50(5):708-717
pubmed: 29686388
Nat Protoc. 2006;1(2):729-48
pubmed: 17406303
Genome Res. 2018 Apr;28(4):581-591
pubmed: 29535149
Nat Genet. 2019 Aug;51(8):1263-1271
pubmed: 31358994
Nat Methods. 2017 Apr;14(4):407-410
pubmed: 28218898
Cancer Res. 2008 Dec 1;68(23):9735-45
pubmed: 19047152
Nature. 2019 Nov;575(7784):699-703
pubmed: 31748743
Nature. 2015 Jun 11;522(7555):179-84
pubmed: 26017310

Auteurs

Konstantin Helmsauer (K)

Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.

Maria E Valieva (ME)

RG Development & Disease, Max Planck Institute for Molecular Genetics, Ihnestraße 63-73, 14195, Berlin, Germany.
Institute for Medical and Human Genetics, Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.

Salaheddine Ali (S)

RG Development & Disease, Max Planck Institute for Molecular Genetics, Ihnestraße 63-73, 14195, Berlin, Germany.
Institute for Medical and Human Genetics, Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.
Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.

Rocío Chamorro González (R)

Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.

Robert Schöpflin (R)

RG Development & Disease, Max Planck Institute for Molecular Genetics, Ihnestraße 63-73, 14195, Berlin, Germany.
Institute for Medical and Human Genetics, Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.

Claudia Röefzaad (C)

Experimental and Clinical Research Center (ECRC), Max Delbrück Center for Molecular Medicine and Charité-Universitätsmedizin Berlin, Lindenberger Weg 80, 13125, Berlin, Germany.

Yi Bei (Y)

Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.

Heathcliff Dorado Garcia (H)

Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.

Elias Rodriguez-Fos (E)

Barcelona Supercomputing Center, Joint BSC-CRG-IRB Research Program in Computational Biology, Jordi Girona 29, 08034, Barcelona, Spain.

Montserrat Puiggròs (M)

Barcelona Supercomputing Center, Joint BSC-CRG-IRB Research Program in Computational Biology, Jordi Girona 29, 08034, Barcelona, Spain.

Katharina Kasack (K)

German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center DKFZ, Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.

Kerstin Haase (K)

Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.

Csilla Keskeny (C)

Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.
German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center DKFZ, Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.

Celine Y Chen (CY)

Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.

Luis P Kuschel (LP)

Department of Neurology with Experimental Neurology, Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.

Philipp Euskirchen (P)

German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center DKFZ, Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.
Department of Neurology with Experimental Neurology, Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.
Berlin Institute of Health, Anna-Louisa-Karsch-Str. 2, 10178, Berlin, Germany.

Verena Heinrich (V)

Department of Computational Molecular Biology, Max Planck Institute for Molecular Genetics, Ihnestraße 63-73, 14195, Berlin, Germany.

Michael I Robson (MI)

RG Development & Disease, Max Planck Institute for Molecular Genetics, Ihnestraße 63-73, 14195, Berlin, Germany.

Carolina Rosswog (C)

Department of Experimental Pediatric Oncology, University Children's Hospital of Cologne and Center for Molecular Medicine Cologne (CMMC), University of Cologne, Kerpener Straße 62, 50937, Köln, Germany.

Joern Toedling (J)

Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.

Annabell Szymansky (A)

Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.

Falk Hertwig (F)

Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.

Matthias Fischer (M)

Department of Experimental Pediatric Oncology, University Children's Hospital of Cologne and Center for Molecular Medicine Cologne (CMMC), University of Cologne, Kerpener Straße 62, 50937, Köln, Germany.

David Torrents (D)

Barcelona Supercomputing Center, Joint BSC-CRG-IRB Research Program in Computational Biology, Jordi Girona 29, 08034, Barcelona, Spain.
Institució Catalana de Recerca i Estudis Avançats (ICREA), Passeig Lluís Companys 23, 08010, Barcelona, Spain.

Angelika Eggert (A)

Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.
German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center DKFZ, Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.
Berlin Institute of Health, Anna-Louisa-Karsch-Str. 2, 10178, Berlin, Germany.

Johannes H Schulte (JH)

Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.
German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center DKFZ, Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.
Berlin Institute of Health, Anna-Louisa-Karsch-Str. 2, 10178, Berlin, Germany.

Stefan Mundlos (S)

RG Development & Disease, Max Planck Institute for Molecular Genetics, Ihnestraße 63-73, 14195, Berlin, Germany.
Institute for Medical and Human Genetics, Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.
Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.

Anton G Henssen (AG)

Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany. henssenlab@gmail.com.
Experimental and Clinical Research Center (ECRC), Max Delbrück Center for Molecular Medicine and Charité-Universitätsmedizin Berlin, Lindenberger Weg 80, 13125, Berlin, Germany. henssenlab@gmail.com.
German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center DKFZ, Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. henssenlab@gmail.com.
Berlin Institute of Health, Anna-Louisa-Karsch-Str. 2, 10178, Berlin, Germany. henssenlab@gmail.com.

Richard P Koche (RP)

Berlin Institute of Health, Anna-Louisa-Karsch-Str. 2, 10178, Berlin, Germany. kocher@mskcc.org.
Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, 430 East 67th Street, New York, NY, 10065, USA. kocher@mskcc.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH